Anger Emotional Stress Influences VEGF/VEGFR2 and Its Induced PI3K/AKT/mTOR Signaling Pathway

Neural Plasticity

Volumn 2016, Issue , 2016, Pages

  Sun, Peng ^a   Wei, Sheng ^a   Wei, Xia ^b   Wang, Jieqiong ^a   Zhang, Yuanyuan ^a   Qiao, Mingqi ^a   Wu, Jibiao ^a  

^a SHANDONG UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b Technical Office of Pharmacology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN; PROTEIN KINASE B; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2; KDR PROTEIN, RAT; MTOR PROTEIN, RAT; TARGET OF RAPAMYCIN KINASE; VASCULOTROPIN A;

AGGRESSION; ANGER; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EMOTIONAL STRESS; HIPPOCAMPUS; MALE; NERVE CELL LESION; NERVE CELL PLASTICITY; NONHUMAN; OPEN FIELD BEHAVIOR; PROTEIN EXPRESSION; RAT; RESIDENT-INTRUDER TEST; SIGNAL TRANSDUCTION; SOCIAL ISOLATION; SUCROSE PREFERENCE TEST; SYNAPTIC INHIBITION; WEIGHT GAIN; ANIMAL; ANIMAL MODEL; DOMINANT-SUBORDINATE RELATIONSHIP; MENTAL STRESS; METABOLISM; NERVE CELL; PHOSPHORYLATION; PHYSIOLOGY; SPRAGUE DAWLEY RAT; WISTAR RAT;

ANGER; ANIMALS; DOMINANCE-SUBORDINATION; HIPPOCAMPUS; MALE; MODELS, ANIMAL; NEURONS; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR; SIGNAL TRANSDUCTION; SOCIAL ISOLATION; STRESS, PSYCHOLOGICAL; TOR SERINE-THREONINE KINASES; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84959506602     PISSN: 20905904     EISSN: 16875443     Source Type: Journal    
DOI: 10.1155/2016/4129015     Document Type: Article

References (47)

1. A. L. Chapman and K. L. Dixon-Gordon, "Emotional antecedents and consequences of deliberate self-harm and suicide attempts," Suicide and Life-Threatening Behavior, vol. 37, no. 5, pp. 543-552, 2007.
2. K. B. Koh and J. K. Park, "The relation between anger management style and organ system-related somatic symptoms in patients with depressive disorders and somatoform disorders," Yonsei Medical Journal, vol. 49, no. 1, pp. 46-52, 2008.
3. D. S. Reddy and K. H. Jian, "The testosterone-derived neurosteroid androstanediol is a positive allosteric modulator of GABAA receptors," Journal of Pharmacology and Experimental Therapeutics, vol. 334, no. 3, pp. 1031-1041, 2010.
4. J. L. Aikey, J. G. Nyby, D. M. Anmuth, and P. J. James, "Testosterone rapidly reduces anxiety in male house mice (Mus musculus)," Hormones and Behavior, vol. 42, no. 4, pp. 448-460, 2002.
5. V. Michopoulos, M. Checchi, D. Sharpe, and M. E. Wilson, "Estradiol effects on behavior and serum oxytocin are modified by social status and polymorphisms in the serotonin transporter gene in female rhesus monkeys," Hormones and Behavior, vol. 59, no. 4, pp. 528-535, 2011.
6. G. Ambar and S. Chiavegatto, "Anabolic-androgenic steroid treatment induces behavioral disinhibition and downregulation of serotonin receptor messenger RNA in the prefrontal cortex and amygdala of male mice," Genes, Brain and Behavior, vol. 8, no. 2, pp. 161-173, 2009.
7. E. F. Coccaro, M. S. McCloskey, D. A. Fitzgerald, and K. L. Phan, "Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression," Biological Psychiatry, vol. 62, no. 2, pp. 168-178, 2007.
8. R. J. R. Blair, "The amygdala and ventromedial prefrontal cortex in morality and psychopathy," Trends in Cognitive Sciences, vol. 11, no. 9, pp. 387-392, 2007.
9. B. Derntl, C. Windischberger, S. Robinson et al., "Amygdala activity to fear and anger in healthy young males is associated with testosterone," Psychoneuroendocrinology, vol. 34, no. 5, pp. 687-693, 2009.
10. S. J. Stanton, M. M. Wirth, C. E. Waugh, and O. C. Schultheiss, "Endogenous testosterone levels are associated with amygdala and ventromedial prefrontal cortex responses to anger faces in men but not women," Biological Psychology, vol. 81, no. 2, pp. 118-122, 2009.
11. A. S. New, E. A. Hazlett, M. S. Buchsbaum et al., "Amygdala-prefrontal disconnection in borderline personality disorder," Neuropsychopharmacology, vol. 32, no. 7, pp. 1629-1640, 2007.
12. M. A. de Souza Silva, B. Topic, J. P. Huston, and C. Mattern, "Intranasal administration of progesterone increases dopaminergic activity in amygdala and neostriatum of male rats," Neuroscience, vol. 157, no. 1, pp. 196-203, 2008.
13. M. Giammanco, G. Tabacchi, S. Giammanco, D. Di Majo, and M. La Guardia, "Testosterone and aggressiveness," Medical Science Monitor, vol. 11, no. 4, pp. RA136-RA145, 2005.
14. J. Archer, "The influence of testosterone on human aggression," British Journal of Psychology, vol. 82, no. 1, pp. 1-28, 1991.
15. C. C. C. Cohen-Bendahan, J. K. Buitelaar, S. H. M. van Goozen, J. F. Orlebeke, and P. T. Cohen-Kettenis, "Is there an effect of prenatal testosterone on aggression and other behavioral traits? A study comparing same-sex and opposite-sex twin girls," Hormones and Behavior, vol. 47, no. 2, pp. 230-237, 2005.
16. A receptor positive modulators in mice," Psychopharmacology, vol. 182, no. 1, pp. 116-127, 2005.
17. E. W. Fish, S. Faccidomo, J. F. DeBold, and K. A. Miczek, "Alcohol, allopregnanolone and aggression in mice," Psychopharmacology, vol. 153, no. 4, pp. 473-483, 2001.
18. B. Segebladh, E. Bannbers, L. Moby et al., "Allopregnanolone serum concentrations and diurnal cortisol secretion in women with premenstrual dysphoric disorder," Archives of Women's Mental Health, vol. 16, no. 2, pp. 131-137, 2013.
19. P. Monteleone, S. Luisi, A. Tonetti et al., "Allopregnanolone concentrations and premenstrual syndrome," European Journal of Endocrinology, vol. 142, no. 3, pp. 269-273, 2000.
20. S. S. Girdler, P. A. Straneva, K. C. Light, C. A. Pedersen, and A. L. Morrow, "Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder," Biological Psychiatry, vol. 49, no. 9, pp. 788-797, 2001.
21. P. R. Albert, F. Vahid-Ansari, and C. Luckhart, "Serotonin-prefrontal cortical circuitry in anxiety and depression phenotypes: pivotal role of pre- and post-synaptic 5-HT1A receptor expression," Frontiers in Behavioral Neuroscience, vol. 8, article 199, 2014.
22. S. S. Newton, N. M. Fournier, and R. S. Duman, "Vascular growth factors in neuropsychiatry," Cellular and Molecular Life Sciences, vol. 70, no. 10, pp. 1739-1752, 2013.
23. J. Greene, M. Banasr, B. Lee, J. Warner-Schmidt, and R. S. Duman, "Vascular endothelial growth factor signaling is required for the behavioral actions of antidepressant treatment: pharmacological and cellular characterization," Neuropsychopharmacology, vol. 34, no. 11, pp. 2459-2468, 2009.
24. M. L. Seibenhener and M. C. Wooten, "Use of the Open Field Maze to measure locomotor and anxiety-like behavior in mice," Journal of Visualized Experiments, no. 96, Article ID e52434, 2015.
25. X. Zhu, T. Li, S. Peng, X. Ma, X. Chen, and X. Zhang, "Maternal deprivation-caused behavioral abnormalities in adult rats relate to a non-methylation-regulated D2 receptor levels in the nucleus accumbens," Behavioural Brain Research, vol. 209, no. 2, pp. 281-288, 2010.
26. M. Gross and A. Pinhasov, "Chronic mild stress in submissive mice: marked polydipsia and social avoidance without hedonic deficit in the sucrose preference test," Behavioural Brain Research, vol. 298, pp. 25-34, 2016.
27. G. Dagyt, I. Crescente, F. Postema et al., "Agomelatine reverses the decrease in hippocampal cell survival induced by chronic mild stress," Behavioural Brain Research, vol. 218, no. 1, pp. 121- 128, 2011.
28. Y. Guo, H. Zhang, J. Gao et al., "Study of genes associated with the 'anger-in' and 'anger-out' emotions of humans using a rat model," Experimental and Therapeutic Medicine, vol. 9, no. 4, pp. 1448-1454, 2015.
29. G. Gan, H. Lv, W. Xie, and R. Zhou, "Morphological identification and development of neurite in Drosophila ventral nerve cord neuropil," PLoS ONE, vol. 9, no. 8, Article ID e105497, 2014.
30. C. Wang, T. Feng, Q. Wan, Y. Kong, and L. Yuan, "miR-124 controls Drosophila behavior and is required for neural development," International Journal of Developmental Neuroscience, vol. 38, pp. 105-112, 2014.
31. J. Peng, C. Wang, C. Wan et al., "miR-184 is Critical for the motility-related PNS development in Drosophila," International Journal of Developmental Neuroscience, vol. 46, pp. 100-107, 2015.
32. Ý real-time PCR system for detection of Listeria monocytogenes in food. Performance Tested Method 011002," Journal of AOAC International, vol. 94, no. 5, pp. 1481-1489, 2011.
33. J. Kaur and A. K. Bachhawat, "A modified Western blot protocol for enhanced sensitivity in the detection of a membrane protein," Analytical Biochemistry, vol. 384, no. 2, pp. 348-349, 2009.
34. H.-P. Ho, M. Olsson, L. Westberg, J. Melke, and E. Eriksson, "The serotonin reuptake inhibitor fluoxetine reduces sex steroid-related aggression in female rats: an animal model of premenstrual irritability?" Neuropsychopharmacology, vol. 24, no. 5, pp. 502-510, 2001.
35. L. J. Siever, "Neurobiology of aggression and violence," The American Journal of Psychiatry, vol. 165, no. 4, pp. 429-442, 2008.
36. S. Schamborg, R. J. Tully, and K. D. Browne, "The use of the state - trait anger expression inventory - II with forensic populations: a psychometric critique," International Journal of Offender Therapy and Comparative Criminology, 2015.
37. X.-J. Liu, Z.-Y. Li, Z.-F. Li et al., "Urinary metabonomic study using a CUMS rat model of depression," Magnetic Resonance in Chemistry, vol. 50, no. 3, pp. 187-192, 2012.
38. O. Berton, M. Durand, S. Aguerre, P. Mormède, and F. Chaouloff, "Behavioral, neuroendocrine and serotonergic consequences of single social defeat and repeated fluoxetine pretreatment in the Lewis rat strain," Neuroscience, vol. 92, no. 1, pp. 327-341, 1999.
39. N. N. Kudryavtseva, "A sensory contact model for the study of aggressive and submissive behavior in male mice," Aggressive Behavior, vol. 17, no. 5, pp. 285-291, 1991.
40. J. D. Higley, P. T. Mehlman, R. E. Poland et al., "CSF testosterone and 5-HIAA correlate with different types of aggressive behaviors," Biological Psychiatry, vol. 40, no. 11, pp. 1067-1082, 1996.
41. M. Virkkunen, R. Rawlings, R. Tokola et al., "CSF biochemistries, glucose metabolism, and diurnal activity rhythms in alcoholic, violent offenders, fire setters, and healthy volunteers," Archives of General Psychiatry, vol. 51, no. 1, pp. 20-27, 1994.
42. P. H. Soloff, T. M. Kelly, S. J. Strotmeyer, K. M. Malone, and J. J. Mann, "Impulsivity, gender, and response to fenfluramine challenge in borderline personality disorder," Psychiatry Research, vol. 119, no. 1-2, pp. 11-24, 2003.
43. E. F. Coccaro, J. M. Silverman, H. M. Klar, T. B. Horvath, and L. J. Siever, "Familial correlates of reduced central serotonergic system function in patients with personality disorders," Archives of General Psychiatry, vol. 51, no. 4, pp. 318-324, 1994.
44. A. S. Unis, E. H. Cook, J. G. Vincent et al., "Platelet serotonin measures in adolescents with conduct disorder," Biological Psychiatry, vol. 42, no. 7, pp. 553-559, 1997.
45. M. Nomura and Y. Nomura, "Psychological, neuroimaging, and biochemical studies on functional association between impulsive behavior and the 5-HT2A receptor gene polymorphism in humans," Annals of the New York Academy of Sciences, vol. 1086, pp. 134-143, 2006.
46. G. K. Boora, R. Kanwar, A. A. Kulkarni et al., "Exome-level comparison of primary well-differentiated neuroendocrine tumors and their cell lines," Cancer Genetics, vol. 208, no. 7-8, pp. 374-381, 2015.
47. T.-J. Liu, D. Koul, T. LaFortune et al., "NVP-BEZ235, a novel dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor, elicits multifaceted antitumor activities in human gliomas," Molecular Cancer Therapeutics, vol. 8, no. 8, pp. 2204-2210, 2009.